Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liposomal collagen is a dietary supplement formulation in which collagen peptides are encapsulated within liposomes—microscopic lipid vesicles—designed to enhance the absorption and bioavailability of collagen when administered, typically via oral or topical routes. Collagen is a structural protein critical for connective tissue health, including skin, joints, and bone. The liposomal delivery mechanism helps protect collagen peptides from degradation in the digestive tract or enhances penetration through the skin barrier, potentially improving efficacy for anti-aging, skin hydration, elasticity, and joint support compared to conventional collagen supplements. There is some evidence from topical studies that liposomal collagen can increase retention of collagen in skin models and promote higher expression of skin structure proteins versus native collagen[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on liposomal collagen.